View in EDS

Design and synthesis of Tetrahydroindeno[4,5-c]chromen-4(3H)-one derivatives as antiproliferative agents for prostate Cancer cells.

Saved in:
Bibliographic Details
Title: Design and synthesis of Tetrahydroindeno[4,5-c]chromen-4(3H)-one derivatives as antiproliferative agents for prostate Cancer cells.
Authors: Chan HY; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan; Department of Pharmacy, Changhua Christian Hospital, Changhua 500, Taiwan., Huang PS; School of Pharmacy, College of Medicine, National Taiwan University, Taipei 100, Taiwan., Chiu PF; School of Pharmacy, College of Medicine, National Taiwan University, Taipei 100, Taiwan., Lin TS; School of Pharmacy, College of Medicine, National Taiwan University, Taipei 100, Taiwan., Huang LJ; School of Pharmacy, College of Medicine, National Taiwan University, Taipei 100, Taiwan., Liang PH; School of Pharmacy, College of Medicine, National Taiwan University, Taipei 100, Taiwan., Guh JH; School of Pharmacy, College of Medicine, National Taiwan University, Taipei 100, Taiwan., Lin MH; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan. Electronic address: mhl00001@tmu.edu.tw.
Source: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2026 Apr; Vol. 133, pp. 130515. Date of Electronic Publication: 2025 Dec 24.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3405 (Electronic) Linking ISSN: 0960894X NLM ISO Abbreviation: Bioorg Med Chem Lett Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41453691
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Design and synthesis of Tetrahydroindeno[4,5-c]chromen-4(3H)-one derivatives as antiproliferative agents for prostate Cancer cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chan+HY%22">Chan HY</searchLink>; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan; Department of Pharmacy, Changhua Christian Hospital, Changhua 500, Taiwan.<br /><searchLink fieldCode="AU" term="%22Huang+PS%22">Huang PS</searchLink>; School of Pharmacy, College of Medicine, National Taiwan University, Taipei 100, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chiu+PF%22">Chiu PF</searchLink>; School of Pharmacy, College of Medicine, National Taiwan University, Taipei 100, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lin+TS%22">Lin TS</searchLink>; School of Pharmacy, College of Medicine, National Taiwan University, Taipei 100, Taiwan.<br /><searchLink fieldCode="AU" term="%22Huang+LJ%22">Huang LJ</searchLink>; School of Pharmacy, College of Medicine, National Taiwan University, Taipei 100, Taiwan.<br /><searchLink fieldCode="AU" term="%22Liang+PH%22">Liang PH</searchLink>; School of Pharmacy, College of Medicine, National Taiwan University, Taipei 100, Taiwan.<br /><searchLink fieldCode="AU" term="%22Guh+JH%22">Guh JH</searchLink>; School of Pharmacy, College of Medicine, National Taiwan University, Taipei 100, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lin+MH%22">Lin MH</searchLink>; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan. Electronic address: mhl00001@tmu.edu.tw.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229107377%22">Bioorganic & medicinal chemistry letters</searchLink> [Bioorg Med Chem Lett] 2026 Apr; Vol. 133, pp. 130515. <i>Date of Electronic Publication: </i>2025 Dec 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9107377 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1464-3405 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220960894X%22">0960894X </searchLink><i>NLM ISO Abbreviation: </i>Bioorg Med Chem Lett <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41453691
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.bmcl.2025.130515
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 130515
    Titles:
      – TitleFull: Design and synthesis of Tetrahydroindeno[4,5-c]chromen-4(3H)-one derivatives as antiproliferative agents for prostate Cancer cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chan HY
      – PersonEntity:
          Name:
            NameFull: Huang PS
      – PersonEntity:
          Name:
            NameFull: Chiu PF
      – PersonEntity:
          Name:
            NameFull: Lin TS
      – PersonEntity:
          Name:
            NameFull: Huang LJ
      – PersonEntity:
          Name:
            NameFull: Liang PH
      – PersonEntity:
          Name:
            NameFull: Guh JH
      – PersonEntity:
          Name:
            NameFull: Lin MH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2026 Apr
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1464-3405
          Numbering:
            – Type: volume
              Value: 133
          Titles:
            – TitleFull: Bioorganic & medicinal chemistry letters
              Type: main
ResultId 1